BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37652084)

  • 1. The impact of lymph node ratio on disease recurrence in papillary thyroid microcarcinoma.
    de Jong MC; Mahipal M; Ngiam KY; Tan WB; Yang SP; Parameswaran R
    Ann R Coll Surg Engl; 2023 Sep; 105(7):632-638. PubMed ID: 37652084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal value of lymph node ratio and metastatic lymph node size to predict risk of recurrence in pediatric thyroid cancer with lateral neck metastasis.
    Back K; Kim TH; Lee J; Kim JS; Choe JH; Oh YL; Cho A; Kim JH
    J Pediatr Surg; 2023 Mar; 58(3):568-573. PubMed ID: 35973863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph node ratio predicts recurrence in pediatric papillary thyroid cancer.
    Rubinstein JC; Dinauer C; Herrick-Reynolds K; Morotti R; Callender GG; Christison-Lagay ER
    J Pediatr Surg; 2019 Jan; 54(1):129-132. PubMed ID: 30361076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymph node ratio of the central compartment is a significant predictor for locoregional recurrence after prophylactic central neck dissection in patients with thyroid papillary carcinoma.
    Ryu IS; Song CI; Choi SH; Roh JL; Nam SY; Kim SY
    Ann Surg Oncol; 2014 Jan; 21(1):277-83. PubMed ID: 24006096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How Many Nodes to Take? Lymph Node Ratio Below 1/3 Reduces Papillary Thyroid Cancer Nodal Recurrence.
    Weitzman RE; Justicz NS; Kamani D; Kyriazidis N; Chen MH; Randolph GW
    Laryngoscope; 2022 Sep; 132(9):1883-1887. PubMed ID: 35229306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal Cut-Off Values of Lymph Node Ratio Predicting Recurrence in Papillary Thyroid Cancer.
    Lee SG; Ho J; Choi JB; Kim TH; Kim MJ; Ban EJ; Lee CR; Kang SW; Jeong JJ; Nam KH; Jung SG; Jo YS; Lee J; Chung WY
    Medicine (Baltimore); 2016 Feb; 95(5):e2692. PubMed ID: 26844509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for level V metastasis in patients with N1b papillary thyroid cancer.
    Kang JG; Choi JE; Kang SH
    World J Surg Oncol; 2022 Sep; 20(1):327. PubMed ID: 36180912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Papillary Thyroid Microcarcinoma Presenting with Palpable Lateral Lymphadenopathy.
    Papachristos A; Do K; Tsang VH; Sywak M; Gill AJ; Sidhu S; Clifton-Bligh RJ; Glover A; Gild ML
    Thyroid; 2022 Sep; 32(9):1086-1093. PubMed ID: 35703333
    [No Abstract]   [Full Text] [Related]  

  • 9. Analysis of risk factors for cervical lymph node metastasis of papillary thyroid microcarcinoma: a study of 268 patients.
    Gu JH; Zhao YN; Xie RL; Xu WJ; You DL; Zhao ZF; Wang F; Fei J
    BMC Endocr Disord; 2019 Nov; 19(1):124. PubMed ID: 31729977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the diagnostic performances of ultrasonography, CT and fine needle aspiration cytology for the prediction of lymph node metastasis in patients with lymph node dissection of papillary thyroid carcinoma: A retrospective cohort study.
    Eun NL; Son EJ; Kim JA; Gweon HM; Kang JH; Youk JH
    Int J Surg; 2018 Mar; 51():145-150. PubMed ID: 29337176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Clinical Significance of Lymph Node Ratio and Ki-67 Expression in Papillary Thyroid Cancer.
    Lindfors H; Ihre Lundgren C; Zedenius J; Juhlin CC; Shabo I
    World J Surg; 2021 Jul; 45(7):2155-2164. PubMed ID: 33825961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical Lymph Node Metastases After Thyroidectomy for Papillary Thyroid Carcinoma Usually Remain Stable for Years.
    Tomoda C; Sugino K; Matsuzu K; Uruno T; Ohkuwa K; Kitagawa W; Nagahama M; Ito K
    Thyroid; 2016 Dec; 26(12):1706-1711. PubMed ID: 27616725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of lymph node ratio in children and adolescents with papillary thyroid cancer.
    Xu Y; Wang Y; Zhang X; Huang R; Tian R; Liu B
    Clin Endocrinol (Oxf); 2021 Oct; 95(4):649-656. PubMed ID: 33914928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension.
    Randolph GW; Duh QY; Heller KS; LiVolsi VA; Mandel SJ; Steward DL; Tufano RP; Tuttle RM;
    Thyroid; 2012 Nov; 22(11):1144-52. PubMed ID: 23083442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central lymph node metastasis in papillary thyroid microcarcinoma can be stratified according to the number, the size of metastatic foci, and the presence of desmoplasia.
    Cho SY; Lee TH; Ku YH; Kim HI; Lee GH; Kim MJ
    Surgery; 2015 Jan; 157(1):111-8. PubMed ID: 25444224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraoperative diagnosis of central compartment lymph node metastasis predicts recurrence of patients with papillary thyroid carcinoma and clinically node-negative lateral neck and may guide extent of initial surgery.
    Lee CW; Gong G; Roh JL
    World J Surg; 2015 Jan; 39(1):194-202. PubMed ID: 25234198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph node ratio in lateral neck is an independent risk factor for recurrence-free survival in papillary thyroid cancer patients with positive lymph nodes.
    Luo Z; Hei H; Qin J; Zheng C; Gong W
    Endocrine; 2022 Dec; 78(3):484-490. PubMed ID: 36018538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
    Wu MH; Shen WT; Gosnell J; Duh QY
    Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nodal Factors Predictive of Recurrence After Thyroidectomy and Neck Dissection for Papillary Thyroid Carcinoma.
    Nam SH; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Thyroid; 2018 Jan; 28(1):88-95. PubMed ID: 29117854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restratification of survival prognosis of N1b papillary thyroid cancer by lateral lymph node ratio and largest lymph node size.
    Kim HI; Kim TH; Choe JH; Kim JH; Kim JS; Oh YL; Hahn SY; Shin JH; Jang HW; Kim YN; Kim H; Ahn HS; Kim K; Kim SW; Chung JH
    Cancer Med; 2017 Oct; 6(10):2244-2251. PubMed ID: 28857489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.